150 related articles for article (PubMed ID: 17367883)
1. Effects of ICD implantation on quality-adjusted life years in patients with congestive heart failure.
Ozasa N; Morimoto T; Furukawa Y; Shizuta S; Nishiyama K; Kita T; Kimura T
Int J Cardiol; 2008 Jan; 123(2):213-6. PubMed ID: 17367883
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
3. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.
Hernandez AF; Fonarow GC; Hammill BG; Al-Khatib SM; Yancy CW; O'Connor CM; Schulman KA; Peterson ED; Curtis LH
Circ Heart Fail; 2010 Jan; 3(1):7-13. PubMed ID: 20009044
[TBL] [Abstract][Full Text] [Related]
6. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator.
Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N
Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710
[TBL] [Abstract][Full Text] [Related]
7. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
[TBL] [Abstract][Full Text] [Related]
8. [Good experiences with an implantable automatic defibrillator with transvenous electrodes for patients with life-threatening arrhythmias].
Jessurun ER; Hutten BA; van Hemel NM; Kelder JC; Defauw JJ; Bakema H
Ned Tijdschr Geneeskd; 1997 Jul; 141(30):1475-80. PubMed ID: 9542881
[TBL] [Abstract][Full Text] [Related]
9. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
Amin MS; Fox AD; Kalahasty G; Shepard RK; Wood MA; Ellenbogen KA
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1275-80. PubMed ID: 18662180
[TBL] [Abstract][Full Text] [Related]
10. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
[TBL] [Abstract][Full Text] [Related]
11. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
13. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
[TBL] [Abstract][Full Text] [Related]
16. [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy].
van Gelder IC; Smit MD; Nieuwland W; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2238-44. PubMed ID: 17076357
[TBL] [Abstract][Full Text] [Related]
17. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
[TBL] [Abstract][Full Text] [Related]
18. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
[TBL] [Abstract][Full Text] [Related]
19. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
[TBL] [Abstract][Full Text] [Related]
20. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]